Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
Tanya Siddiqi, Sandra H Thomas, Robert Chen City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USA Abstract: Brentuximab vedotin (BV) is an antibody-drug conjugate that targets CD30-positive malignancies via an anti-CD30 monoclonal antibody linked to monomethy...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2014-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |